Spok Holdings Inc (SPOK) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Spok Holdings Inc (SPOK) has a cash flow conversion efficiency ratio of 0.017x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($2.44 Million) by net assets ($140.96 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Spok Holdings Inc balance sheet independence to measure how much of total assets are equity-financed.
Spok Holdings Inc - Cash Flow Conversion Efficiency Trend (2000–2025)
This chart illustrates how Spok Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Spok Holdings Inc to evaluate the quality of earnings relative to operating cash generation.
Spok Holdings Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Spok Holdings Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
RoadMain T Co Ltd
SHG:603860
|
-0.023x |
|
Synopex Inc
KQ:025320
|
0.012x |
|
Taiwan Kong King Co Ltd
TWO:3093
|
0.115x |
|
Laboratorio Reig Jofre S.A
MC:RJF
|
0.052x |
|
Huafang Co Ltd
SHG:600448
|
0.148x |
|
EVI Industries Inc
NYSE MKT:EVI
|
0.007x |
|
Celon Pharma SA
WAR:CLN
|
-0.009x |
|
Neon Equity AG
XETRA:D77
|
N/A |
Annual Cash Flow Conversion Efficiency for Spok Holdings Inc (2000–2025)
The table below shows the annual cash flow conversion efficiency of Spok Holdings Inc from 2000 to 2025. For the full company profile with market capitalisation and key ratios, see SPOK market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $146.38 Million | $28.95 Million | 0.198x | +5.81% |
| 2024-12-31 | $154.75 Million | $28.92 Million | 0.187x | +16.90% |
| 2023-12-31 | $163.77 Million | $26.18 Million | 0.160x | +326.15% |
| 2022-12-31 | $172.08 Million | $6.46 Million | 0.038x | -18.22% |
| 2021-12-31 | $173.69 Million | $7.97 Million | 0.046x | -64.82% |
| 2020-12-31 | $200.61 Million | $26.16 Million | 0.130x | +178.94% |
| 2019-12-31 | $250.09 Million | $11.69 Million | 0.047x | +24.45% |
| 2018-12-31 | $274.55 Million | $10.31 Million | 0.038x | -29.83% |
| 2017-12-31 | $290.53 Million | $15.56 Million | 0.054x | -53.96% |
| 2016-12-31 | $322.09 Million | $37.46 Million | 0.116x | +2.06% |
| 2015-12-31 | $333.55 Million | $38.01 Million | 0.114x | -23.48% |
| 2014-12-31 | $279.06 Million | $41.56 Million | 0.149x | -20.32% |
| 2013-12-31 | $269.95 Million | $50.46 Million | 0.187x | -35.52% |
| 2012-12-31 | $251.42 Million | $72.88 Million | 0.290x | -11.24% |
| 2011-12-31 | $252.44 Million | $82.44 Million | 0.327x | -26.04% |
| 2010-12-31 | $184.39 Million | $81.42 Million | 0.442x | -31.16% |
| 2009-12-31 | $158.80 Million | $101.86 Million | 0.641x | -14.87% |
| 2008-12-31 | $140.74 Million | $106.04 Million | 0.753x | +146.29% |
| 2007-12-31 | $373.57 Million | $114.28 Million | 0.306x | -1.11% |
| 2006-12-31 | $475.97 Million | $147.24 Million | 0.309x | +18.40% |
| 2005-12-31 | $532.99 Million | $139.25 Million | 0.261x | +33.38% |
| 2004-12-31 | $583.34 Million | $114.27 Million | 0.196x | -64.74% |
| 2003-12-31 | $326.26 Million | $181.25 Million | 0.556x | -69.30% |
| 2002-12-31 | $114.22 Million | $206.66 Million | 1.809x | +6428.13% |
| 2001-12-31 | $-1.66 Billion | $47.37 Million | -0.029x | +91.66% |
| 2000-12-31 | $-94.26 Million | $32.33 Million | -0.343x | -- |
About Spok Holdings Inc
Spok Holdings, Inc., through its subsidiary, Spok, Inc., engages in the healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. Its products and services enhance workflows for clinicians and support administrative compliance. The company delivers clinical information to care teams when and where it matters to enhance patient outcomes; and pro… Read more